Product Name
Frizzled 4 (FZD4), Peptide
Full Product Name
Frizzled 4 (Frizzled-4, Frizzled (Drosophila) Homolog 4, Fz 4, Fz-4, FZD4, FZD4S, FzE4, CD344 Antigen, EVR1, FEVR, GPCR, hFz4, MGC34390, WNT Receptor Frizzled-4, Exudative vitreoretinopathy 1 Autosomal Dominant Criswick-Schepens Syndrome) (Control Peptide
Product Synonym Names
Frizzled 4 (Frizzled-4, Frizzled (Drosophila) Homolog 4, Fz 4, Fz-4, FZD4, FZD4S, FzE4, CD344 Antigen, EVR1, FEVR, GPCR, hFz4, MGC34390, WNT Receptor Frizzled-4, Exudative vitreoretinopathy 1 Autosomal Dominant Criswick-Schepens Syndrome) (Control Peptide
Product Gene Name
FZD4 peptide
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 11; NC_000011.9 (86656717..86666440, complement). Location: 11q14.2
3D Structure
ModBase 3D Structure for Q9ULV1
Specificity
Recognizes human FNIP1. Species Crossreactivity: rat.
Purity/Purification
Highly Purified
Highly Purified
Form/Format
Supplied as a lyophilized powder in PBS.
Preparation and Storage
May be stored at 4 degree C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20 degree C. Aliquots are stable for at least 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Other Notes
Small volumes of FZD4 peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
FZD4 peptide
C-terminus of aa-DEEERRCDPIRIS.
Product Categories/Family for FZD4 peptide
Molecular Biology; MB-Disease Markers
Applications Tested/Suitable for FZD4 peptide
ELISA (EL/EIA)
Application Notes for FZD4 peptide
Suitable for use in ELISA.
NCBI/Uniprot data below describe general gene information for FZD4. It may not necessarily be applicable to this product.
NCBI Accession #
AAR23924.1
[Other Products]
UniProt Primary Accession #
Q9ULV1
[Other Products]
UniProt Secondary Accession #
Q14C97; Q6S9E4; A8K9Q3[Other Products]
UniProt Related Accession #
Q9ULV1[Other Products]
Molecular Weight
59,881 Da[Similar Products]
NCBI Official Full Name
frizzled 4
NCBI Official Synonym Full Names
frizzled family receptor 4
NCBI Official Symbol
FZD4??[Similar Products]
NCBI Official Synonym Symbols
Fz4; EVR1; FEVR; Fz-4; FzE4; GPCR; hFz4; CD344; FZD4S
??[Similar Products]
NCBI Protein Information
frizzled-4; frizzled homolog 4; WNT receptor frizzled-4; frizzled 4, seven transmembrane spanning receptor
UniProt Protein Name
Frizzled-4
UniProt Synonym Protein Names
FzE4
UniProt Gene Name
FZD4??[Similar Products]
UniProt Synonym Gene Names
Fz-4; hFz4??[Similar Products]
UniProt Entry Name
FZD4_HUMAN
NCBI Summary for FZD4
This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This protein may play a role as a positive regulator of the Wingless type MMTV integration site signaling pathway. A transcript variant retaining intronic sequence and encoding a shorter isoform has been described, however, its expression is not supported by other experimental evidence. [provided by RefSeq, Jul 2008]
UniProt Comments for FZD4
Function: Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin (CTNNB1) canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin (CTNNB1) and activation of Wnt target genes. Plays a critical role in retinal vascularization by acting as a receptor for Wnt proteins and norrin (NDP). In retina, it can be both activated by Wnt protein-binding, but also by a Wnt-independent signaling via binding of norrin (NDP), promoting in both cases beta-catenin (CTNNB1) accumulation and stimulation of LEF/TCF-mediated transcriptional programs. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues.
Subunit structure: Interacts with MAGI3 and norrin (NDP). Component of a complex, at least composed of TSPAN12, FZD4 and norrin (NDP)
By similarity.
Subcellular location: Membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein
By similarity.
Tissue specificity: Almost ubiquitous. Largely expressed in ***** heart, skeletal muscle, ovary, and fetal kidney. Moderate amounts in ***** liver, kidney, pancreas, spleen, and fetal lung, and small amounts in placenta, ***** lung, prostate, testis, colon, fetal brain and liver.
Domain: Lys-Thr-X-X-X-Trp motif interacts with the PDZ doman of Dvl (Disheveled) family members and is involved in the activation of the Wnt/beta-catenin signaling pathway
By similarity.The FZ domain is involved in binding with Wnt ligands
By similarity.
Post-translational modification: Ubiquitinated by ZNRF3, leading to its degradation by the proteasome. Ref.7
Involvement in disease: Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. In many ways the disease resembles retinopathy of prematurity but there is no evidence of prematurity or small birth weight in the patient history.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.18 Ref.19 Ref.20 Ref.21
Sequence similarities: Belongs to the G-protein coupled receptor Fz/Smo family.Contains 1 FZ (frizzled) domain.
Research Articles on FZD4
1. Six different nonsynonymous DNA variants are identified in the coding region of either the FZD4 gene (p.H69Y, p.R127H, and p.Y211H) or the LRP5 gene (p.R1219H, p.H1383P, and p.T1540M) in seven patients with advanced retinopathy of prematurity
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.